Symbol Stock Price change today
MKTX MarketAxess Holdings Inc. 4.881%
SUI Sun Communities Inc 2.2098%
ULTA Ulta Beauty Inc 1.4979%
LULU Lululemon Athletica inc. 1.0619%
EA Electronic Arts Inc. 1.0312%
DPZ Domino's Pizza, Inc. 0.8006%
WCG WellCare Health Plans, Inc. -0.1302%
SBUX Starbucks Corporation -0.1444%
TNET TriNet Group Inc -0.3616%
CBPO China Biologic Products Holdings Inc -0.4986%
LGIH LGI Homes Inc -0.5251%
TGS Transportadora de Gas del Sur SA (ADR) -0.6074%
UNH UnitedHealth Group Inc -0.6982%
V Visa Inc -0.8786%
BKNG Booking Holdings Inc -1.0065%
MA Mastercard Inc -1.0622%
NSP Insperity Inc -1.1542%
BABA Alibaba Group Holding Ltd -1.1981%
AMN AMN Healthcare Services, Inc. -1.304%
ADBE Adobe Systems Incorporated -1.3151%
GOOGL Alphabet Inc Class A -1.3296%
ANET Arista Networks Inc -1.3631%
ILMN Illumina, Inc. -1.3785%
KNX Knight-Swift Transportation Holdings Inc -1.3914%
HZO MarineMax Inc -1.3924%
PYPL Paypal Holdings Inc -1.49%
MKSI MKS Instruments, Inc. -1.6109%
ABMD ABIOMED, Inc. -1.678%
AAPL Apple Inc. -1.8116%
JAZZ Jazz Pharmaceuticals PLC -1.9141%
AVGO Broadcom Inc -1.9406%
REGN Regeneron Pharmaceuticals Inc -2.0262%
COHR Coherent, Inc. -2.0824%
MU Micron Technology, Inc. -2.1309%
MTZ MasTec, Inc. -2.2087%
LRCX Lam Research Corporation -2.245%
AMZN Amazon.com, Inc. -2.2711%
SWKS Skyworks Solutions Inc -2.4022%
CRUS Cirrus Logic, Inc. -2.4027%
NFLX Netflix, Inc. -2.4357%
NVDA NVIDIA Corporation -2.6238%
AMAT Applied Materials, Inc. -2.6667%
CVGW Calavo Growers, Inc. -2.8873%
FB Facebook, Inc. Common Stock -3.0272%
TMUS T-Mobile Us Inc -3.4066%
PATK Patrick Industries, Inc. -3.4556%
GTN Gray Television, Inc. -3.9041%
ALGN Align Technology, Inc. -4.156%
THRM Gentherm Inc -4.3745%
NXST Nexstar Media Group Inc -4.437%
ALXN Alexion Pharmaceuticals, Inc. -5.6519%
STZ Constellation Brands, Inc. Class A -5.7878%
MEI Methode Electronics Inc. -6.9513%

 

Company name Knight-Swift Transportation Holdings Inc
Stock ticker KNX
Live stock price [stckqut]KNX[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $42.8
Target stock price (averages with growth) $41.51
Target stock price (averages with no growth) $41.51
Target stock price (manual assumptions) $42.15

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Knight-Swift Transportation Holdings Inc as long as the indicators that I describe in my book The Confident Investor are favorable.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Knight-Swift Transportation Holdings Inc calculated?

For owners of my book, "The Confident Investor" I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.

I hope that this makes you a Confident Investor.

 

Company name Jazz Pharmaceuticals PLC
Stock ticker JAZZ
Live stock price [stckqut]JAZZ[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $193.92
Target stock price (averages with growth) $188.33
Target stock price (averages with no growth) $188.33
Target stock price (manual assumptions) $185.87

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/jazz

Jazz Pharmaceuticals Public Limited Company, incorporated on March 15, 2005, is a biopharmaceutical company. The Company is focused on developing and commercializing products that address unmet medical needs. The Company has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. The Company's lead marketed products include Xyrem (sodium oxybate oral solution) for the treatment of both cataplexy and excessive daytime sleepiness in patients with narcolepsy; Erwinaze for the treatment of acute lymphoblastic leukemia (ALL), and Defitelio (defibrotide) for the treatment of severe hepatic veno-occlusive disease (VOD).

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Jazz Pharmaceuticals PLC as long as the indicators that I describe in my book The Confident Investor are favorable.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Jazz Pharmaceuticals PLC calculated?

For owners of my book, "The Confident Investor" I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.

I hope that this makes you a Confident Investor.

 

Company name Illumina, Inc.
Stock ticker ILMN
Live stock price [stckqut]ILMN[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Fair
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $469.32
Target stock price (averages with growth) $473.94
Target stock price (averages with no growth) $473.94
Target stock price (manual assumptions) $446.85

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/ilmn

Illumina, Inc. (Illumina), incorporated on May 16, 2000, is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. GRAIL is engaged in developing a blood test for early-stage cancer detection. Helix was established to enable individuals to explore their genetic information by providing sequencing and database services for consumers through third-party partners.

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Illumina, Inc. as long as the indicators that I describe in my book The Confident Investor are favorable.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Illumina, Inc. calculated?

For owners of my book, "The Confident Investor" I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.

I hope that this makes you a Confident Investor.

 

Company name Installed Building Products Inc
Stock ticker IBP
Live stock price [stckqut]IBP[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Poor
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $58.11
Target stock price (averages with growth) $57.37
Target stock price (averages with no growth) $57.37
Target stock price (manual assumptions) $54.66

 

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/ibp

Installed Building Products, Inc., incorporated on October 28, 2011, is a holding company. The Company is a residential insulation installer in the United States. As of December 31, 2016, the Company's national platform included over 100 locations accessing customers in 48 continental states and the District of Columbia. The Company also installs complementary building products, including garage doors, rain gutters, shower doors, closet shelving and mirrors, which provides cross-selling opportunities to supplement the insulation installation business. It also provides roof installation services. The Company manages various aspects of the installation process for the customers, from the direct purchase and receipt of materials from national manufacturers, to supply of materials to job sites and quality installation. The Company's customers include production and custom homebuilders, multi-family and commercial contractors, and homeowners.

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Installed Building Products Inc as long as the price is correct and the indicators that I describe in my book The Confident Investor are favorable. Most of the fundamentals of this company are good but there are some concerns. I have decided to remove Installed Building Products from my WatchList.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Installed Building Products Inc calculated?

For owners of my book, "The Confident Investor" I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.

I hope that this makes you a Confident Investor.